coming later
Myo-inositol · 2000 mg · 40:1 formulation; serving-level amount
Price not listed
Inositol · Decision hub
Inositol is a naturally occurring carbohydrate-like compound found in many foods and produced in the body, and it is available as a supplement in several forms — most commonly myo-inositol and D-chiro-inositol, alone or in combination. Labels carry several facts that decide what you actually get: the inositol form(s) named, the amount per serving, the serving size, and what else is in the container. This hub explains what inositol is, how myo-inositol and D-chiro-inositol relate, and how to compare real products on declared amount, testing, and standardized value.
Pick your question
Pick the question closest to yours. Each one opens the existing HerbParlor tool or comparison that answers it — no sponsored rankings, no hidden ordering.
Start here
Inositol is a naturally occurring carbohydrate-like compound — a cyclohexanehexol, sometimes described informally as a sugar alcohol — found in a wide variety of foods including fruits, beans, grains, and nuts, and also produced in the human body. It has historically been referred to as “vitamin B8,” though it is not considered a true vitamin because the body can produce it. As a dietary supplement, inositol is provided as a single identified form or as a combination of forms, most often as a powder, capsules, or tablets.
Two products can both say “inositol” and differ in every detail that matters. The label may name a specific form — myo-inositol, D-chiro-inositol, or inositol without further specification — and it declares how much a serving provides, how large a serving is, and what excipients or other ingredients are included. Some products combine myo-inositol and D-chiro-inositol in a stated ratio; that ratio is a label fact to compare only where it is actually documented, not a quality verdict or a recommendation.
This hub does not recommend a particular inositol form, ratio, amount, or product for any health outcome. It explains what the labels mean and how to compare products on declared facts.
Forms & sources
These terms describe the chemical forms of inositol and how they are presented on a label. The facts that matter for comparison are the form(s) named, the declared amount per serving, the serving size, and the additional ingredients — read together, not in isolation. This hub does not claim that any form or ratio is universally superior.
Health benefits / health context
Inositol is a naturally occurring compound found in many foods and produced in the human body. Within normal physiology, inositol participates in several cellular processes, including the inositol phosphate signaling pathway, and myo-inositol is involved in insulin signaling as part of an inositol-containing mediator. These are descriptions of normal biological roles, not claims about what a supplement does.
Research on inositol supplementation is especially concentrated around polycystic ovary syndrome (PCOS) and metabolic/reproductive outcomes, where most human trials have been conducted. Outside these areas — for example, mood, anxiety, sleep, and general metabolic health in people without PCOS — the evidence base is smaller and more variable, and findings should not be assumed to transfer from PCOS populations to other groups or to the general population.
Within the PCOS and metabolic research, studies have examined insulin sensitivity and metabolic measures (such as HOMA-IR and fasting insulin), hormonal and biochemical measures (such as testosterone-related measures and sex hormone–binding globulin), and reproductive endpoints (such as ovulation and menstrual-cycle-related measures). These are distinct layers of evidence: a change in a biomarker or surrogate measure is not the same as a demonstrated patient-important clinical outcome such as pregnancy or live birth, and a finding in one formulation or population should not be generalized to all inositol products or all people.
This section describes what inositol is in general terms. It does not claim that any inositol supplement treats, prevents, or cures any condition, including polycystic ovary syndrome (PCOS), infertility, insulin resistance, diabetes, metabolic syndrome, gestational diabetes, mood or anxiety conditions, or any other condition. It does not claim that inositol guarantees ovulation, pregnancy, weight loss, hormonal balance, or reversal of insulin resistance. Whether an inositol supplement is appropriate, in which form and at what amount, is a decision for a healthcare professional — especially for people who take medications, are pregnant or nursing, or have a medical condition.
What research says
Inositol — particularly myo-inositol and D-chiro-inositol — has been studied in relation to insulin sensitivity, metabolic health, reproductive outcomes (especially PCOS-related outcomes), and mood-related outcomes, among others. The summary below orients you using recent 2026 syntheses where available; it is not a treatment or dosing recommendation, and results vary by form, amount, population, and the outcome studied. Condition-specific findings are presented as research context only, not as individualized treatment advice. It helps to keep five layers distinct: (1) hormonal/biochemical biomarkers such as testosterone-related measures and SHBG; (2) metabolic surrogate outcomes such as HOMA-IR and fasting insulin; (3) reproductive endpoints such as ovulation and menstrual-cycle measures; (4) patient-important clinical outcomes such as pregnancy or live birth; and (5) evidence quality and uncertainty. A change in one layer does not automatically translate into a guaranteed benefit in another.
What the research landscape looks like
A 2026 umbrella review of meta-analyses from randomized controlled trials — “Effects of inositol in women with polycystic ovary syndrome: an umbrella review of meta-analyses from randomized controlled trials” (PubMed PMID 41757236) — included 13 meta-analyses covering hormonal, metabolic, anthropometric, and reproductive measures. Some pooled outcomes favored inositol, including testosterone-related measures, sex hormone–binding globulin (SHBG), HOMA-IR, fasting insulin, and selected reproductive outcomes. However, evidence quality was highly variable: across the 85 evidence items, no high-quality GRADE evidence was identified; 18.9% were moderate quality, 40% low quality, and 41.1% very low quality. Cross-subtype findings suggested differences between myo-inositol and D-chiro-inositol, but these should not be turned into a universal formulation recommendation. This umbrella review does not prove that inositol treats PCOS, and its pooled findings are research context, not treatment advice.
A 2026 systematic review and meta-analysis — “Metabolic Phenotype Predicts Biochemical Response to Inositol Supplementation in Polycystic Ovary Syndrome” (PubMed PMID 41947399) — pooled 9 RCTs and 440 participants and reported significant reductions in total testosterone, calculated free testosterone, and free androgen index, with increased SHBG. Several outcomes showed substantial heterogeneity. The apparent stronger response in normal-weight participants was exploratory, and no significant improvement was detected in overweight/obese or insulin-resistant subgroups when considered independently of BMI. The authors emphasize the need for adequately powered phenotype-stratified trials and clinically meaningful outcomes. These are hormonal/biochemical biomarker changes, not established patient-important clinical outcomes, and they should not be generalized across formulations, ratios, or populations.
Several 2026 syntheses report changes in hormonal and biochemical biomarkers — such as testosterone-related measures, free androgen index, and SHBG — in women with PCOS. A biomarker change is a surrogate measure: it is not the same as a demonstrated patient-important clinical outcome such as pregnancy or live birth, and it does not by itself establish that inositol treats PCOS or any condition. This hub records biomarker findings as research context and does not convert them into guaranteed clinical benefits.
Because myo-inositol participates in insulin signaling, studies have examined inositol in relation to metabolic surrogate measures such as HOMA-IR and fasting insulin. Pooled findings in the 2026 umbrella review favored inositol for some of these measures, but with highly variable evidence quality. A change in HOMA-IR or fasting insulin is a surrogate measure and is not the same as a demonstrated clinical outcome for diabetes prevention or treatment. This hub does not recommend an inositol product for insulin resistance, diabetes, metabolic syndrome, or gestational diabetes, and does not claim that inositol reverses insulin resistance. Any use for a specific metabolic concern is a decision for a healthcare professional.
A body of research has examined myo-inositol, and myo-inositol combined with D-chiro-inositol, in relation to reproductive endpoints in women with PCOS, including ovulation and menstrual-cycle-related measures. Results vary by population, form, amount, and ratio studied. Reproductive endpoints such as ovulation are distinct from patient-important outcomes such as pregnancy or live birth, and this hub does not claim that inositol guarantees ovulation, pregnancy, or improved fertility. This is research context only — it is not individualized treatment advice, and this hub does not recommend an inositol product, form, or ratio for PCOS, fertility, or any reproductive outcome. Such decisions belong with a healthcare professional.
Some research has examined myo-inositol in relation to mood- and anxiety-related outcomes. Results are not uniform and vary by population and amount, and the evidence base outside PCOS and metabolic research is smaller and more variable. No outcome is established here as a supplement effect, and this hub does not recommend an inositol product for any mood or anxiety condition, and does not claim that inositol treats depression or anxiety. Any use for a specific concern is a decision for a healthcare professional.
Studies use different forms (myo-inositol, D-chiro-inositol, or combinations), different amounts, and sometimes specific myo-inositol to D-chiro-inositol ratios. Because the form and ratio are part of the intervention, a finding from one formulation cannot automatically be generalized to another — a study of myo-inositol alone does not establish the same effect for a D-chiro-inositol product or a 40:1 combination, and vice versa. Formulation identity matters when interpreting a clinical study. A studied amount or ratio is not a recommendation, and this hub does not endorse any particular ratio or claim that a specific ratio (including “40:1”) is universally superior unless supported by the relevant evidence. Compare the declared form(s), amounts, and serving size together rather than treating any one as a quality ranking.
The 2026 umbrella review explicitly found no high-quality GRADE evidence across 85 evidence items, with most rated low or very low quality, and the 2026 biochemical-hyperandrogenism meta-analysis reported substantial heterogeneity and called for adequately powered phenotype-stratified trials. This means pooled findings are hypothesis-supporting orientation, not established treatment outcomes. This hub does not present mixed, early, or low-quality findings as established outcomes and does not recommend a supplemental dose for any clinical purpose.
Intake & dosage reference
There is no government-established recommended daily intake or tolerable upper intake level for inositol from authoritative bodies in the way there is for vitamins and minerals. Amounts in supplements vary — myo-inositol products commonly declare servings in the gram range, while D-chiro-inositol is typically declared in smaller amounts. This is general reference information for understanding labels, not an individualized dose or a treatment recommendation.
| Group | Reference value |
|---|---|
| Common myo-inositol amount per serving | Typically in the gram range (varies by product) |
| Common D-chiro-inositol amount per serving | Typically smaller amounts than myo-inositol (varies by product) |
| Recommended daily intake | No established daily reference value for inositol |
| Tolerable upper intake level | Not established for inositol |
| Studied dosing | Varies by study, form, and outcome; not generalizable across products |
These are not personal dosing instructions. Studied amounts depend on the form, the outcome studied, and the population, and a higher amount is not automatically better. Any amount or ratio used in research is a studied value, not a recommendation. Dosing for any clinical purpose — especially for people who take medications (including insulin or blood-sugar-lowering therapies), are pregnant or nursing, or have a medical condition — is a decision for a healthcare professional.
Safety & side effects
Inositol is generally reported to be well tolerated in studies at common supplemental amounts, and side effects when they occur are often mild and digestive in nature. Anyone who takes medications, is pregnant or nursing, or has a medical condition should discuss use with a healthcare professional before starting.
The more important safety considerations apply to people on insulin or blood-sugar-lowering therapies, to combination products that add other active ingredients, and to people using inositol for a condition-specific purpose. These are general orientation points, not an exhaustive list.
Gastrointestinal effects such as nausea, gas, bloating, or loose stools have been reported in some individuals, particularly at higher amounts. Effects can vary by person and by amount. If effects persist or worsen, stop use and discuss with a healthcare professional.
Because myo-inositol participates in insulin signaling, inositol supplementation could in principle affect blood sugar. If you take insulin or any blood-sugar-lowering medication, or have diabetes or a related condition, discuss use with a healthcare professional before starting and monitor as advised. This is general orientation, not a treatment instruction.
Products that combine inositol with vitamins (such as folate or other B vitamins), minerals, or botanical extracts carry the safety considerations of those added ingredients, which are separate from inositol alone. Read the full label and treat a combination product as distinct from pure inositol. See the Folate, B-Complex, and Multivitamin hubs for more on those ingredients.
Research on inositol in relation to PCOS, fertility, insulin sensitivity, metabolic health, and mood is presented here as research context only. Using an inositol supplement for any condition-specific purpose — including the form, amount, and ratio — is a decision for a healthcare professional, not a self-treatment recommendation from this hub.
Whether an inositol supplement is appropriate in pregnancy, while nursing, or alongside any medical condition or medication is a decision for a healthcare professional. This hub does not recommend an inositol product, form, ratio, or amount for any specific situation or outcome.
Interactions & important considerations
Because inositol participates in insulin signaling, the most relevant interactions concern insulin and blood-sugar-lowering therapies, and combination products carry their own considerations. This is general orientation, not an exhaustive list — check with a pharmacist or doctor about your own medications and health situation.
Sources
The context and terminology above are drawn from publicly available authoritative and scientific sources. HerbParlor does not independently verify the contents of third-party sites, and does not endorse any specific study’s conclusions as established health advice.
Effects of inositol in women with polycystic ovary syndrome: an umbrella review of meta-analyses from randomized controlled trials
Peer-reviewed literature (PubMed PMID 41757236, National Library of Medicine) · 2026 umbrella review of meta-analyses
Peer-reviewed literature (PubMed PMID 41757236, National Library of Medicine)Retrieved 2026-09-11
Metabolic Phenotype Predicts Biochemical Response to Inositol Supplementation in Polycystic Ovary Syndrome
Peer-reviewed literature (PubMed PMID 41947399, National Library of Medicine) · 2026 systematic review and meta-analysis of RCTs
Peer-reviewed literature (PubMed PMID 41947399, National Library of Medicine)Retrieved 2026-09-11
Inositol — scientific literature
Peer-reviewed literature (indexed via PubMed, National Library of Medicine) · Scientific literature database
Peer-reviewed literature (indexed via PubMed, National Library of Medicine)Retrieved 2026-09-08
Dietary Supplements — overview
NIH Office of Dietary Supplements · Government dietary supplement information
NIH Office of Dietary SupplementsRetrieved 2026-09-08
Dietary Supplement Labeling Guide
U.S. Food and Drug Administration · Regulatory labeling guidance
U.S. Food and Drug AdministrationRetrieved 2026-09-08
Decision criteria
No single inositol product is “best” for everyone, and no inositol product is established as effective for any health outcome. These neutral criteria help you narrow the field to the products worth comparing side by side. They use only the facts HerbParlor already structures and scores — nothing here is influenced by affiliate availability, commission, merchant, or a sponsored ranking.
A short, neutral pass before you commit. Each step uses an existing HerbParlor tool — no new accounts, no sponsored ordering. If you take medications (especially insulin or blood-sugar-lowering therapies), are pregnant or nursing, or have a medical condition, talk to your clinician before choosing any inositol product. Remember that no inositol product is established as effective for any health outcome.
Compare
Use the same criteria for every product. These are the facts HerbParlor structures and scores on — and the ones worth checking yourself before you decide. The facts that matter most are the inositol form(s) named, the declared amount per serving, and the serving size; none alone tells you what you get.
Whether the label names “myo-inositol,” “D-chiro-inositol,” a combination with a stated ratio, or only “inositol” without specifying the form. Form specificity is one of HerbParlor’s scored dimensions; a label that names the form is more specific than one that does not. This hub does not claim that any form or ratio is universally superior.
How much inositol a serving delivers, stated in grams (g) or milligrams (mg). Compare in a single consistent unit so two products are measured the same way. For combination products, check the declared amount of each form separately. A higher amount is not automatically better — compare it alongside the form, serving size, and testing.
A serving may be one scoop of powder, one or more capsules, or one or more tablets. Serving size and servings per container decide how many doses you are comparing and how long a container lasts — both feed the standardized value.
If a product combines myo-inositol and D-chiro-inositol, note whether it states a ratio and what the declared amount of each form is. A stated ratio is a label fact, not a recommendation, and this hub does not endorse any particular ratio. Treat a combination product as a distinct formulation, not a stronger version of a single form.
A clear ingredient list, named excipients, any fillers, binders, flavourings, sweeteners, added vitamins (such as folate or other B vitamins), minerals, or botanical extracts, and capsule or tablet material are part of HerbParlor’s transparency scoring. Missing or vague disclosure is reported as unavailable, not silently treated as a failure or a pass.
Whether the product reports third-party testing, a named lab, or certifications — and whether that is independent verification or a brand/retailer claim. These are recorded as attributed, never silently upgraded.
VitaValue™ puts price next to a comparable quantity — cost per comparable unit of inositol — so serving size, format, and packaging don’t disguise the real cost.
Tools
These are HerbParlor’s existing tools, contextualised for inositol. Each one turns research into a shortlist you can act on — no sponsored rankings, no hidden ordering.
Start from your goal — not a product page — and get an evidence-aligned, scored shortlist.
Try the matcherEnter supplement label information and get a structured, neutral ingredient-by-ingredient analysis.
Analyze a labelPlace products side by side and see where each one earns — or loses — its score.
Open comparisonSee standardized cost per comparable unit so price sits next to what you actually get.
Calculate valueSee what testing and certification information HerbParlor has recorded for a product.
Check testing infoReview how much of a product’s profile is disclosed and documented across our eight dimensions.
Check transparencyCompare products
Every product below is a real, canonical record assessed with the same VitaScore™ rubric. Open any product for the full profile, or compare several side by side.
Myo-inositol · 2000 mg · 40:1 formulation; serving-level amount
Price not listed
Wholesome Story
Myo-inositol · 2000 mg · 40:1 formulation; 4-capsule serving
Price not listed
Fairhaven Health
Myo-inositol · 2000 mg · 40:1 formulation; 4-capsule serving
Price not listed
NOW Foods
Myo-inositol · 730 mg · Amount per 1/4 teaspoon serving
Price not listed
Jarrow Formulas
Myo-inositol · 750 mg · Serving-level amount
Price not listed
Life Extension
Myo-inositol · 1000 mg · Serving-level amount
Price not listed
Inositol · 500 mg · Serving-level amount
Price not listed
Nutricost
Myo-inositol · 500 mg · Serving-level amount
Price not listed
Naturecan
Myo-inositol · 1000 mg · Serving-level amount
Price not listed
Nature's Way
Inositol · 500 mg · Serving-level amount
Price not listed
Learn
Editorial explainers that break down the labels, the chemistry, and the comparison framework behind this hub.
Trust & methodology
Every inositol product in this hub is assessed with the same transparent VitaScore™ rubric — eight dimensions covering label transparency, dose transparency, ingredient/form specificity, quality verification, source provenance, product/manufacturer transparency, evidence linkage, and standardized value. The rubric is the same for every product and every category.
VitaScore™ is a transparency and documentation score. It is not a measure of medical effectiveness, safety, or suitability for an individual. A product with more disclosed, documented information scores higher; missing information is reported as unavailable, never silently treated as a failure.
HerbParlor sells nothing and takes no placement fees. Scores cannot be bought, influenced, or negotiated.
We note when products report third-party testing, and say so when a product reports none. A manufacturer or retailer claim is never treated as independent verification.
Commercial relationships do not influence scores, ordering, or what appears on this hub. Retailer links appear only when verified and are kept separate from editorial analysis.
FAQ
This hub is provided for educational purposes only and is not medical advice. It does not claim that any inositol form, source, or product is better for any health outcome. Always consult a qualified healthcare professional before starting any supplement, especially if you are pregnant, nursing, taking medication, or subject to anti-doping rules.